The bioprocess containers market involves a variety of containers used for bioprocessing applications across the biopharmaceutical and biotechnology industries. These containers play a vital role in the storage, transportation, and development of biopharmaceutical drugs. Key containers include bioreactors, storage containers, purification containers, and filtration containers. Bioreactors are widely used for large-scale production of vaccines and therapeutics in the biopharmaceutical industry. Storage containers including bags, carboys, and drums are utilized for storage of raw materials, intermediates, buffers, and final drug products. Containers for purification such as plates and tubes are deployed in the downstream purification process. Filtration containers such as cassettes and cartridges are employed for filtering and sterilizing cellular matter and biomolecules. The growing demand for single-use technologies across biomanufacturing has propelled the adoption of single-use bioprocess containers over traditional stainless-steel alternatives. Their disposable nature reduces cleaning and validation costs, while improving operational flexibility.

The Global bioprocess containers market is estimated to be valued at US$ 9.52 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the bioprocess containers market are Cole-Parmer Instrument Company, LLC., ALLpaQ Packaging Group, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Sartorius AG, Danaher, Entegris, Inc., Avantor, Inc., RIM Bio, Fenner PLC, Lonza, Saint-Gobain, Corning Incorporated. Major players are focusing on new product launches and expansions to meet the growing demand.

Growing demand for bioprocess containers:

The growing Bioprocess Containers Market Size for monoclonal antibodies and recombinant proteins has significantly driven the consumption of bioprocess containers in the biopharmaceutical industry. Furthermore, expansion of biologics manufacturing capacities across major markets will continue to propel the demand.

Global expansion of bioprocess containers market:

Key players are expanding their production sites globally to enhance geographic presence and better serve clinical trials and commercial production requirements. Regional and global presence helps players address regulatory requirements and provide localized supply chain support.

Market Drivers

The primary driver for the bioprocess containers market is the growing adoption of single-use technologies. Single-use bioprocess containers provide multiple advantages over stainless-steel alternatives such as reduced capital costs, elimination of cleaning and cleaning validations. Their disposable nature improves operational flexibility and efficiencies. Furthermore, demand for biologics and biosimilars will continue to drive the need for expanded biomanufacturing capacities, propelling the consumption of associated bioprocess containers.

The global bioprocess containers market is largely influenced by the ongoing geopolitical tensions and conflicts across various regions. Rising security concerns and instability in international relations have disrupted global supply chains and trade networks. This has constrained the transport of bioprocess container products and movement of professionals working in this sector across borders. Additionally, political instability and uncertainty in regions with a concentration of pharmaceutical manufacturing facilities create risks for continued investments and operations of players in this industry. For instance, the ongoing Russia-Ukraine conflict has obstructed product shipments to Eastern Europe and disrupted production activities of some Western companies with operations in Russia. Rising inflationary pressures and regional economic downturns resulting from geopolitical disturbances also negatively impact the marketing and sales budgets of bioprocess container vendors.

To ensure long-term growth, companies must focus on diversifying their manufacturing footprint and supply sources. They need to establish local partnerships and expand into politically stable emerging economies with supportive regulatory frameworks. Adopting a multi-regional or global supply chain approach helps mitigate regional economic and political risks. It also allows firms to cater to the demands of different markets more efficiently. Furthermore, continuous engagement with governments to streamline regulations facilitating international trade would provide more resilience to geopolitical headwinds.

The North American region accounts for the largest market share in terms of value sales of bioprocess containers. This is due to presence of numerous established pharmaceutical firms and biotech companies actively performing R&D and manufacturing activities. Availability of technical expertise and manufacturing infrastructure has also boosted regional market. However, Asia Pacific is projected to be the fastest growing regional market during the forecast period. This can be attributed to rising pharmaceutical production in emerging countries like China and India combined with initiatives to strengthen domestic healthcare industries. In addition, increasing availability of affordable skilled labor and biological drugs has accelerated the shift of pharmaceutical manufacturing to the Asia Pacific region in recent times.

Get more insights on Bioprocess Containers Market